International Society

Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology

Retrieved on: 
Monday, December 11, 2023
Editorial, Quality of life, ESR1, Hospital, ESMO, Medicine, ASCO, Woman, Breast cancer, Fulvestrant, Annals of Oncology, Eli Lilly, Breast, Business model, Progression-free survival, Massachusetts General Hospital, Congress, Society, Trial of the century, International Society, Mutation, Annual general meeting, Neoplasm, Oncology, Patient, PFS, Therapy, Pharmaceutical industry

Also, 30.7% of patients on lasofoxifene achieved a PFS of 12 months compared to 14.1% on fulvestrant.

Key Points: 
  • Also, 30.7% of patients on lasofoxifene achieved a PFS of 12 months compared to 14.1% on fulvestrant.
  • Results were initially shared at a poster discussion session during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and updated in June at ASCO 2023.
  • Annals of Oncology provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.
  • To learn more about Sermonix Pharmaceuticals and lasofoxifene, visit SermonixPharma.com .

Wistar Scientists Identify Esophageal Cancer Biomarkers

Retrieved on: 
Wednesday, December 6, 2023
RNA, Wistar Institute, Ferroptosis, Collaborative writing, RNA-Seq, National Cancer Institute, Biomedical Research, Culture, Mechanics, Tumor microenvironment, Ellen, Virus, ESCA, Messenger, Prognosis, Health, Ageing, Incidence, Neoplasm, Cancer, International Society, University, University of Pennsylvania, Ecology, Gene expression, Gene, Biomarker, Machine learning, Cell, Patient, Qi, Iron, NCI, Bacteriophage, Esophageal cancer, Carnegie Mellon University

Philadelphia, PA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology.

Key Points: 
  • Philadelphia, PA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wistar scientists have developed a new tool that can help identify cancer-associated microbes by using machine learning technology.
  • Under the leadership of Dr. Noam Auslander — assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular & Cellular Oncogenesis Program — the group has analyzed short read RNA-sequencing data to detect biomarkers for esophageal carcinoma, or ESCA.
  • Since 1972, the Institute has held National Cancer Institute (NCI)-designated Cancer Center status.
  • Wistar scientists are dedicated to solving some of the world’s most challenging problems in the field of cancer and immunology, advancing human health through early-stage discovery and training the next generation of biomedical researchers.

EXP bolsters firm’s presence across North America with promotions and hire of industry leaders

Retrieved on: 
Wednesday, December 6, 2023
EXP, Valparaiso University, Transport, Pharmacy, Chemistry, Project Management Professional, Engineering, American Council, Society, HVAC, International Society, Birla Vishvakarma Mahavidyalaya, Project Management Institute, Florida Atlantic University, Atlantic University, Civil engineering

CHICAGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- EXP recently named four industry leaders vice president to advance progress toward strategic goals across markets.

Key Points: 
  • CHICAGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- EXP recently named four industry leaders vice president to advance progress toward strategic goals across markets.
  • Rachael has a Bachelor of Science in mechanical engineering with a concentration in HVAC from California Polytechnic State University.
  • She is a Professional Engineer in California and a member of the International Society of Pharmaceutical Engineers and I2SL.
  • We are proud to expand our expertise and market presence through the advancement of these industry leaders at EXP.

ISHLT Elects New Board Members and Professional Community Leaders

Retrieved on: 
Friday, December 1, 2023
Lung transplantation, TDM, Chairperson, Infection, Annual, FCCP, Transplant, Tissue engineering, MBA, Pediatrics, International Society, Pulmonary heart disease, Heart transplantation, Pulmonary hypertension, Care, Society, Sarcoidosis, Research, MCS, Standard, COVID-19, Publication, Management

The Society will welcome four new members to the Board of Directors and 16 leaders across ISHLT’s professional specialty communities to serve as representatives to the 4 ISHLT Interdisciplinary Network Steering Committees and the Early Career & Trainee Committee.

Key Points: 
  • The Society will welcome four new members to the Board of Directors and 16 leaders across ISHLT’s professional specialty communities to serve as representatives to the 4 ISHLT Interdisciplinary Network Steering Committees and the Early Career & Trainee Committee.
  • Professor Josef Stehlik, MD, will serve as ISHLT President-Elect beginning in May 2024 and as ISHLT President beginning in May 2025.
  • The elected members of the Board of Directors are:
    Professor Stehlik’s areas of interest include advanced heart failure, heart transplantation, mechanical circulatory support, cardiac sarcoidosis, and cardioversion.
  • Beginning 1 May, 2024, the new composition of the Board will be:
    The elected Professional Community leaders are:

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Retrieved on: 
Thursday, November 30, 2023
Health, Princeton University, Morgan Stanley, Endeavor (non-profit), MBA, AHN, CBO, Nikhil, Harvard Business School, International Society, Chronic kidney disease, Business development, Transplant, Patient, Service, Dialysis, Berkshire Partners, CKD

WINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Nikhil Pereira-Kamath, MBA, Vice President of Business Development & Innovative Solutions, to Chief Business Officer (CBO).

Key Points: 
  • WINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the appointment of Nikhil Pereira-Kamath, MBA, Vice President of Business Development & Innovative Solutions, to Chief Business Officer (CBO).
  • As CBO, Nikhil will have global responsibility for commercial strategy, defining the Company’s growth and partnering activities, business development, and investor relations.
  • “Nik’s broad experience in new business development and strategic partnerships will be an invaluable asset as the Company moves through late-stage clinical development and towards potential commercialization of our lead program,” said Bruce Culleton, Chief Executive Officer of ProKidney.
  • Prior to joining ProKidney, he was Chief Executive Officer and subsequently Executive Chairman, a role he continues to hold, of Africa Healthcare Network (AHN), the largest independent provider of dialysis and kidney care in sub-Saharan Africa.

Hyaluronic Acid Raw Material Market Forecasted to Reach USD 10.8 Billion by 2030 with Notable CAGR of 6.5% - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 28, 2023
Chemicals, Plastics, Manufacturing, Woman, Wound healing, Filler (linguistics), Osteoarthritis, Incidence, USD, International Society, Smith & Nephew, Ophthalmology, Vesicoureteral reflux, Elective surgery, Toxicity, Growth, Medical tourism, Administration, Hyaluronic acid, Salix Pharmaceuticals, Fine chemical

The "Hyaluronic Acid Raw Material Market Size, Share & Trends Analysis Report By Application (Ophthalmology, Orthopedics), By Source (Non-Animal, Animal), By Grade, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hyaluronic Acid Raw Material Market Size, Share & Trends Analysis Report By Application (Ophthalmology, Orthopedics), By Source (Non-Animal, Animal), By Grade, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global hyaluronic acid raw material market size is expected to reach USD 10.8 billion by 2030.
  • The market is expected to expand at a CAGR of 6.5% from 2023 to 2030.
  • Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR.

Major Milestones Achieved Through the ISS National Lab in 2023

Retrieved on: 
Wednesday, December 20, 2023
International Space Station, BioServe Space Technologies, Conference, Workforce, Drug discovery, ISS National Lab, ISS, Student, Astronaut, Commercial Crew Program, SPACE, Consumer Electronics Show, United States national laboratories, Research, Tissue engineering, ISSCR, Cancer Moonshot, Axiom Space, DNA, Education, LEO, NASA, Government, Eli Lilly and Company, International Society, NSF, Temperature, Science, Knowledge, Ageing, Medication, Boeing, CCP, Patient, Gene, Bristol Myers Squibb, CES, ASCEND, Alzheimer's disease, Orbit, Human outpost

In fiscal year 2023, more than 110 ISS National Lab-sponsored payloads were delivered to the orbiting laboratory—the most ever in a single year.

Key Points: 
  • In fiscal year 2023, more than 110 ISS National Lab-sponsored payloads were delivered to the orbiting laboratory—the most ever in a single year.
  • A wide range of research and technology development was conducted through the ISS National Lab this year.
  • Many ISS National Lab research successes have been highlighted in Upward, official magazine of the ISS National Lab , which serves to communicate valuable results to the scientific community.
  • To learn more about how to join the expanding ISS National Lab research community, visit the Current Opportunities page on our website .

Productlife Group Acquires LifeBee, Strengthening Its Capacity To Support Digital Transformation In Life Sciences

Retrieved on: 
Wednesday, December 20, 2023
Community, PLG, Acquisition, ISPE, Gartner, GxP, International Board, International Society, Human, Knowledge, Medication, Digitalization, Management

PARIS, Dec. 20, 2023 /PRNewswire-PRWeb/ -- The acquisition will bolster ProductLife Group Consulting and Digitalization services, playing a crucial role in PLG's pursuit to become the premier leader in life sciences consulting worldwide. LifeBee brings a strong strategic approach, coupled with cutting-edge digital expertise that will further build on PLG's consulting capabilities. LifeBee has recurrently been mentioned as a representative player in life sciences by Gartner and has a relevant and active presence in renowned industry associations, like the International Society for Pharmaceutical Engineering (ISPE), providing its contribution both on a strategical and knowledge-sharing level.

Key Points: 
  • ProductLife Group (PLG), the global consulting provider of regulatory, scientific, vigilance and quality services for the life sciences industries, announces the acquisition of LifeBee, a leading Italian and Swiss based consulting firm providing digital transformation, operational excellence and proactive compliance services in life sciences.
  • Current LifeBee shareholders will reinvest in PLG Group, embracing the PLG mission while guaranteeing business continuity for all clients.
  • PARIS, Dec. 20, 2023 /PRNewswire-PRWeb/ -- The acquisition will bolster ProductLife Group Consulting and Digitalization services, playing a crucial role in PLG's pursuit to become the premier leader in life sciences consulting worldwide.
  • LifeBee brings a strong strategic approach, coupled with cutting-edge digital expertise that will further build on PLG's consulting capabilities.

PRODUCTLIFE GROUP ACQUIRES LIFEBEE, STRENGTHENING ITS CAPACITY TO SUPPORT DIGITAL TRANSFORMATION IN LIFE SCIENCES

Retrieved on: 
Wednesday, December 20, 2023
Community, PLG, Acquisition, ISPE, Gartner, GxP, International Board, International Society, Human, Knowledge, Medication, Digitalization, Management

PARIS, Dec. 20, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global consulting provider of regulatory, scientific, vigilance and quality services for the life sciences industries, announces the acquisition of LifeBee, a leading Italian and Swiss based consulting firm providing digital transformation, operational excellence and proactive compliance services in life sciences.

Key Points: 
  • PARIS, Dec. 20, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global consulting provider of regulatory, scientific, vigilance and quality services for the life sciences industries, announces the acquisition of LifeBee, a leading Italian and Swiss based consulting firm providing digital transformation, operational excellence and proactive compliance services in life sciences.
  • Current LifeBee shareholders will reinvest in PLG Group, embracing the PLG mission while guaranteeing business continuity for all clients.
  • The acquisition will bolster ProductLife Group Consulting and Digitalization services, playing a crucial role in PLG's pursuit to become the premier leader in life sciences consulting worldwide.
  • LifeBee brings a strong strategic approach, coupled with cutting-edge digital expertise that will further build on PLG's consulting capabilities.

The Inner Circle Acknowledges, Haris Choudry as a Distinguished Healthcare Provider for his contributions to the fields of Physiatry and Orthopedics

Retrieved on: 
Tuesday, December 19, 2023
PM&R, Mentorship, Quality of life, Hospital, Inner circle, Public, Tendon, SUNY Downstate Medical Center, Joint, Medical director, Chronic pain, Spinal cord, Brain, Health, MD, Bachelor, Physical medicine and rehabilitation, Education, Disability, University, International Society, Knowledge, Ligament, Amputation, PM, Clinical, Medicine, Public health, Arthritis

NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Haris Choudry is acknowledged as a Distinguished Healthcare Provider for his contributions to the fields of Physiatry and Orthopedics.

Key Points: 
  • NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Haris Choudry is acknowledged as a Distinguished Healthcare Provider for his contributions to the fields of Physiatry and Orthopedics.
  • Dr. Choudry pursued higher education at the University of Oklahoma where he earned a Bachelor's degree in Biochemistry.
  • He then continued at the University of Oklahoma College of Medicine where he received his medical degree and completed his residency in physical medicine & rehabilitation at SUNY Downstate Health Sciences University.
  • Physiatrists treat a wide variety of medical conditions affecting the brain, spinal cord, nerves, bones, joints, ligaments, muscles, and tendons.